Skyhawk Therapeutics Appoints Guerciolini Chief Medical Officer

Xconomy Boston — 

Roberto Guerciolini is now chief medical officer of Skyhawk Therapeutics. Guerciolini’s experience includes posts at Wave Life Sciences (NASDAQ: WVE), SIRNA Therapeutics, and Dicerna Pharmaceuticals (NASDAQ: DRNA). Waltham, MA-based Skyhawk is developing RNA-targeting drugs to treat cancer and neurological diseases. Skyhawk launched a little more than a year ago; last June, the company landed a partnership with Celgene (NASDAQ: CELG) and simultaneously announced a $40 million round of funding.